With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To make this a reality, adMare uses its scientific and commercial expertise, specialized infrastructure, and investment capital to build new companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term. Our 25+ portfolio companies have attracted more than $1.4 billion of investment, have a combined value of over $3 billion, and employ more than 900 Canadians. Our Innovation Centres are home to 35+ biotech companies, contract research organizations, and specialized commercialization support organizations. The adMare Academy has trained more than 500 alumni – 95% of whom are now working to build our life sciences industry.